3-아릴-5-알킬-1,2,4-옥사다이아졸 유도체, 그 제조방법 및이를 포함하는 비만 예방 또는 치료용 조성물
    1.
    发明授权
    3-아릴-5-알킬-1,2,4-옥사다이아졸 유도체, 그 제조방법 및이를 포함하는 비만 예방 또는 치료용 조성물 失效
    3-芳基-5-烷基-1,2,4-氧杂噻唑衍生物及其制备方法,以及用于预防或治疗含有其的成分的组合物

    公开(公告)号:KR100847448B1

    公开(公告)日:2008-07-21

    申请号:KR1020070028181

    申请日:2007-03-22

    Abstract: 3-Aryl-5-alkyl-1,2,4-oxadiazole derivatives are provided to reduce eating by competing with MCH R1(melanin-concentrating hormone receptor subtype-1) associated with obesity, so that the compounds are useful for preventing or treating obesity. The 3-aryl-5-alkyl-1,2,4-oxadiazole derivatives represented by the formula(1) are useful as antagonist of MCH R1, wherein R1 is (C3-C5) branched alkyl, (C1-C3)dialkylamino(C1-C3)alkyl or (C1-C3) linear alkyl which is optionally substituted by pyridine, piperidine or (C5-C7) cycloalkyl; R2 is halogen-substituted phenyl, CF3-substituted phenyl, phenyl substituted by phenoxy which is optionally substituted by halogen or (benzo[1,3]dioxol-5-yl)phenyl; and X is -NHCO or -NHCONH-. A method for preparing the 3-aryl-5-alkyl-1,2,4-oxadiazole derivatives represented by the formula(1a) comprises the steps of: (1) reacting 4-aminobenzonitrile represented by the formula(2) with organic acid(R2COOH) in the presence of solvent and binding reagent to prepare amide compounds represented by the formula(3); (2) reacting the amide compounds represented by the formula(3) with hydroxylamine hydrochloride in the presence of solvent to prepare amidoxime represented by the formula(4); and (3) reacting the amidoxime represented by the formula(4) with another organic acid(R1COOH) in the presence of solvent and binding reagent to prepare 1,2,4-oxadiazole ring.

    Abstract translation: 提供3-芳基-5-烷基-1,2,4-恶二唑衍生物以通过与与肥胖相关的MCH R1(黑色素浓缩激素受体亚型-1)竞争来减少进食,使得该化合物可用于预防或治疗 肥胖。 由式(1)表示的3-芳基-5-烷基-1,2,4-恶二唑衍生物可用作MCH R 1的拮抗剂,其中R 1是(C 3 -C 5)支链烷基,(C 1 -C 3)二烷基氨基( C1-C3)烷基或任选被吡啶,哌啶或(C5-C7)环烷基取代的(C1-C3)直链烷基; R 2是卤素取代的苯基,CF 3取代的苯基,被苯氧基取代的苯基,其被卤素或(苯并[1,3]二氧杂环戊烯-5-基)苯基任选取代; X是-NHCO或-NHCONH-。 制备由式(1a)表示的3-芳基-5-烷基-1,2,4-恶二唑衍生物的方法包括以下步骤:(1)使由式(2)表示的4-氨基苄腈与有机酸 (R2COOH)在溶剂和结合试剂存在下反应制备式(3)表示的酰胺化合物。 (2)在溶剂存在下使式(3)表示的酰胺化合物与羟胺盐酸盐反应,制备由式(4)表示的偕胺肟; 和(3)在溶剂和结合试剂的存在下使由式(4)表示的偕胺肟与另一种有机酸(R1COOH)反应以制备1,2,4-恶二唑环。

Patent Agency Ranking